Phenoxybenzamine Hydrochloride Capsule shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting 2025-12-01 · last update 2025-12-01
Manufacturers: Advanz Pharma (US) Corp.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Dibenzyline, Capsule, 10 mg (NDC 59212-001-01) | Advanz Pharma (US) Corp. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 12/01/2025 Updated 12/01/2025 Discontinued 12/01/2025 |
| Dibenzyline, Capsule, 10 mg (NDC 59212-001-02) | Advanz Pharma (US) Corp. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 12/01/2025 Updated 12/01/2025 Discontinued 12/01/2025 |
| Dibenzyline, Capsule, 10 mg (NDC 66993-066-02) | Advanz Pharma (US) Corp. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 12/01/2025 Updated 12/01/2025 Discontinued 12/01/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)